Attention subscribers
If you are a current subscriber but do not have an online account, click here to set up your free access.
Not yet a subscriber? click here to subscribe today.
Log in Subscribe

Second patient death reported with gene therapy for muscular dystrophy

Posted 6/16/25

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. The biotech drugmaker said Sunday it was …

This item is available in full to subscribers.

Please log in to continue

Log in